General Framework
Structure
Main National and International Collaborations and Reference Groups
Areas of Research
Main ongoing Research Activities and Projects
Methodologies and Facilities
Selected References
Cardio.Care
Useful links in cardiology
4. AREAS OF RESEARCH

This brief summary of the main directions and methodological approaches adopted by the Department provides a synopsis of the activities and competence available. This information must be integrated with that of section 5, where the ongoing projects are presented in greater detail.

4.1. Experimental Pharmacology
4.2. Clinical Pharmacology
4.3. Controlled Clinical Studies
4.4. Large Scale Clinical Trials
4.5. Clinical Epidemiology
4.6. Health Care Research
4.7. Technology Transfer and International Health
4.8. Nursing Research
4.9. Medical Informatics and Statistics
4.10. Scientific Communication and Training





  • 4.1. Experimental Pharmacology

    Experimental cardiovascular research deals with the short and long-term effects on left ventricular function and structure of myocardial ischemia/reperfusion. Effects of cardiovascular drugs are studied in models of acute and chronic ischemia both in vivo and in rats and mice. The research activities are usually planned and developed in collaboration with clinical groups in order to test (a) new drugs and (b) pathophysiologic hypotheses derived from clinical trials. More recent fields of research are (a) neurohormonal alterations induced by congestive heart failure post-myocardial infarction and (b) cellular mechanisms leading to LV remodelling during senescence.

  • 4.2. Clinical Pharmacology

    Clinical pharmacology is one of the core know-how of many members of the group. Besides the facilities for conducting classical studies on pharmacokinetics and on biochemical markers or mediators, the Department employs methods and instruments of drug epi demiology tailored to its specific fields of interest.

  • 4.3. Controlled Clinical Studies

    Three approaches are grouped under this heading:
    * ad hoc in depth studies within the frameworks and on subpopulations of large-scale clinical trials;
    * experimental and observational investigations of clinical and pathophysiological problems;
    * pilot and small scale trials on pharmacological interventions.

  • 4.4. Large Scale Clinical Trials

    The tradition of the GISSI studies (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto, endorsed by the Istituto Mario Negri and by the Associazione Nazionale Medici Cardiologi Ospedalieri, ANMCO) on acute myocardial infarction (AMI), with the establishment of countrywide research networks representing the routine care of the National Health Service, has been expanded to the fields of acute coronary syndromes, congestive heart failure, primary and secondary prevention of vascular events, peri pheral artery diseases.

  • 4.5. Clinical Epidemiology

    Strategies under this heading include:
    * the epidemiological analysis (risk factors, prognostic indicators, etc.) of the large data bases generated by the population trials;
    * case-control studies;
    * meta-analyses of randomized controlled trials;
    * prospective outcome studies.

  • 4.6. Health Care Research

    A relatively new area of interest which encompasses the following main topics: the assessment of the role of care settings in affecting clinical outcomes; health economy analysis; the components, the determinants, the implications of the medical decision processes with respect to controversial interventions/ technologies; prospective surveys of the quality of care.

  • 4.7. Technology Transfer and International Health

    The know-how developed over the years in supporting WHO policy on essential drugs and clinical pharmacology in developing countries, and the broader interest on the transferability of advanced results into clinical practice, are the basis for the activiti es of close cooperation mainly with countries of Latino-America, and for the participation in multinational epidemiological studies on cardiovascular risk factors.

  • 4.8. Nursing Research

    The increasingly central role of nurses in the conduction of clinical studies, has led over the last several years to the establishment of research networks (including coronary care units, neurological departments, departments of vascular medicine and sur gery) coordinated with (but fully autonomous from) the medical groups in the formulation and implementation of specific studies. The main interests focus on: assessment of health-related quality of life of patients; epidemiology of nursing interventions a nd their implications for patients' well being and outcomes.

  • 4.9. Medical Informatics and Statistics

    The medical informatics and statistics team is actively involved in the management and analyses of most of the clinical and epidemiological studies of the Department. Besides this activity, the team is conducting research in the following fields:
    * design and implementation of clinical trial database management systems;
    * use of the Internet in the management of clinical trials;
    * training on the use of the Internet in cardiology;
    * development of prognostic indexes;
    * development of flexible regression models.

  • 4.10. Scientific Communication and Training

    The activities grouped under this heading occupy an important fraction of the time and resources of the Department:

    * to establish and support the clinical research networks;
    * to favour the appropriate and timely transfer of knowledge to the National Health Service, via publications of bulletins and regular training courses directed to hospital physicians, GPs and other health professionals;
    * to produce and circulate educational material to the general public in the fields of interest of the Department, with special emphasis on prevention.

Home Page Department  Home Page Institute

Department of Cardiovascular Research
"Mario Negri" Institute for Pharmacological Research

Via Eritrea, 62 - 20157 Milano - Italy
Tel. +39-0239014482 Fax. +39-0233200049

 

Scientific Info:DepCardio
Technical Info:Enrico Nicolis